If you suffer from atrial fibrillation (AF) -- a condition where disorganized electrical signals cause the heart's upper chambers to contract quickly and irregularly -- your doctor may prescribe an ...

In the context of "Pharmacology Made Easy 5.0," a test on the cardiovascular system would likely focus on the following key ...

Purpose. The pharmacology, pharmacokinetics, safety, clinical efficacy, and role of intravenous vernakalant hydrochloride for the rapid conversion of atrial fibrillation (AF) to normal sinus rhythm ...

Atrial fibrillation (AF) is the most common cardiac arrhythmia seen in clinical practice, and it contributes substantially to both morbidity and medical costs.1 In this issue Humphries and associates ...

Medications for arrhythmia include antiarrhythmic drugs that restore the heart’s normal rhythm by affecting the heart’s electrical current. Calcium channel blockers can help manage arrhythmia, angina, ...

CHICAGO -- Antiarrhythmic drugs ineffective before atrial fibrillation ablation help prevent recurrence when continued beyond the blanking period after the procedure, the POWDER-AF (Pulmonary Vein ...

In Suspected PE, A-fib Doesn’t Raise Odds of the Diagnosis For patients with paroxysmal atrial fibrillation with no history of antiarrhythmic drug use, there is no significant difference in the ...

Findings reported in The American Journal of Pathology suggest dofetilide may counteract pathological changes in potassium channels associated with pulmonary arterial hypertension in humans and rats ...

Please provide your email address to receive an email when new articles are posted on . Dronedarone is a noniodinated benzofuran derivative of amiodarone that was specifically designed to improve the ...

Pune, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Antiarrhythmic Drugs Market Size & Growth Analysis: “As per SNS Insider Research, the global Antiarrhythmic Drugs Market (抗不整脈薬市場) was valued at USD 1.02 ...

Am J Health Syst Pharm. 2010;67(14):1157-1164. Vernakalant hydrochloride injection, an antiarrhythmic agent under review by the Food and Drug Administration (FDA) for the rapid conversion of AF to ...